vs
Side-by-side financial comparison of BLACKBOXSTOCKS INC. (BLBX) and Mind Medicine (MindMed) Inc. (DFTX). Click either name above to swap in a different company.
Mind Medicine (MindMed) Inc. is the larger business by last-quarter revenue ($906.0K vs $628.4K, roughly 1.4× BLACKBOXSTOCKS INC.). BLACKBOXSTOCKS INC. runs the higher net margin — -255.8% vs -2634.0%, a 2378.2% gap on every dollar of revenue. On growth, BLACKBOXSTOCKS INC. posted the faster year-over-year revenue change (7.4% vs -16.1%).
Blackboxstocks Inc. is a US-based fintech firm operating a subscription trading analytics platform for retail and active traders. It provides real-time market data, trade signals, analytical tools and social trading features for equity, options and digital asset markets, making institutional-grade trading resources accessible to individual users.
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
BLBX vs DFTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $628.4K | $906.0K |
| Net Profit | $-1.6M | $-23.9M |
| Gross Margin | 60.6% | — |
| Operating Margin | -248.0% | -2450.8% |
| Net Margin | -255.8% | -2634.0% |
| Revenue YoY | 7.4% | -16.1% |
| Net Profit YoY | -69.4% | -386.7% |
| EPS (diluted) | — | $-0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $628.4K | — | ||
| Q3 25 | $697.0K | — | ||
| Q2 25 | $518.8K | — | ||
| Q1 25 | $587.1K | — | ||
| Q4 24 | $585.0K | — | ||
| Q3 24 | $647.8K | — | ||
| Q2 24 | $684.7K | — | ||
| Q1 24 | $649.4K | — |
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-720.6K | — | ||
| Q2 25 | $-1.3M | — | ||
| Q1 25 | $-829.1K | — | ||
| Q4 24 | $-948.7K | — | ||
| Q3 24 | $-780.8K | — | ||
| Q2 24 | $-877.9K | — | ||
| Q1 24 | $-863.7K | — |
| Q4 25 | 60.6% | — | ||
| Q3 25 | 53.7% | — | ||
| Q2 25 | 32.2% | — | ||
| Q1 25 | 41.6% | — | ||
| Q4 24 | 26.5% | — | ||
| Q3 24 | 54.7% | — | ||
| Q2 24 | 48.0% | — | ||
| Q1 24 | 44.9% | — |
| Q4 25 | -248.0% | — | ||
| Q3 25 | -63.0% | — | ||
| Q2 25 | -220.4% | — | ||
| Q1 25 | -151.2% | — | ||
| Q4 24 | -151.5% | — | ||
| Q3 24 | -113.3% | — | ||
| Q2 24 | -120.5% | — | ||
| Q1 24 | -133.0% | — |
| Q4 25 | -255.8% | — | ||
| Q3 25 | -103.4% | — | ||
| Q2 25 | -244.7% | — | ||
| Q1 25 | -141.2% | — | ||
| Q4 24 | -162.2% | — | ||
| Q3 24 | -120.5% | — | ||
| Q2 24 | -128.2% | — | ||
| Q1 24 | -133.0% | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $99.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.7M | $78.1M |
| Total Assets | $8.7M | $124.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $60.9K | — | ||
| Q2 24 | $1.1M | — | ||
| Q1 24 | $115.0K | — |
| Q4 25 | $5.7M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $5.8M | — | ||
| Q1 24 | $6.5M | — |
| Q4 25 | $8.7M | — | ||
| Q3 25 | $8.8M | — | ||
| Q2 25 | $9.9M | — | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $9.9M | — | ||
| Q3 24 | $10.0M | — | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $9.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-510.4K | $-20.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-510.4K | — | ||
| Q3 25 | $-955.9K | — | ||
| Q2 25 | $-1.1M | — | ||
| Q1 25 | $-643.7K | — | ||
| Q4 24 | $-24.4K | — | ||
| Q3 24 | $5.8K | — | ||
| Q2 24 | $-333.4K | — | ||
| Q1 24 | $-353.8K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
